General Commentary
Accepted on 17 Feb 2026
Commentary: Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system
in Psychopharmacology
General Commentary
Accepted on 17 Feb 2026
in Psychopharmacology
Editorial
Accepted on 17 Feb 2026
in Mental Health Occupational Therapy
Original Research
Accepted on 17 Feb 2026
in ADHD
Hypothesis and Theory
Accepted on 17 Feb 2026
in Computational Psychiatry
Original Research
Accepted on 17 Feb 2026
in Addictive Disorders
Original Research
Published on 17 Feb 2026
in Adolescent and Young Adult Psychiatry
General Commentary
Published on 17 Feb 2026
in Anxiety and Stress Disorders
Original Research
Published on 17 Feb 2026
in Psychopharmacology
Systematic Review
Published on 17 Feb 2026
in ADHD
Original Research
Published on 17 Feb 2026
in Social Psychiatry and Psychiatric Rehabilitation
Original Research
Published on 17 Feb 2026
in Mood Disorders
Systematic Review
Accepted on 16 Feb 2026
in Public Mental Health
Original Research
Accepted on 16 Feb 2026
in Addictive Disorders
Review
Accepted on 16 Feb 2026
in Addictive Disorders
Original Research
Accepted on 16 Feb 2026
in Aging Psychiatry
Perspective
Accepted on 16 Feb 2026
in Psychopathology
Clinical Trial
Accepted on 16 Feb 2026
in Autism
Review
Accepted on 16 Feb 2026
in Mood Disorders
Original Research
Accepted on 16 Feb 2026
in Anxiety and Stress Disorders
Systematic Review
Accepted on 16 Feb 2026
in Neurostimulation
Review
Accepted on 16 Feb 2026
in Neurostimulation
Original Research
Accepted on 16 Feb 2026
in Public Mental Health
Case Report
Accepted on 16 Feb 2026
in Anxiety and Stress Disorders
Original Research
Accepted on 16 Feb 2026
in Public Mental Health